Select Page

Rheumatoid Arthritis

Below is a sample of existing clinical evidence:

“Treatment induced a significant remission of disease according to the American College of Rheumatology improvement criteria, the 28-joint disease activity score, and the Health Assessment Questionnaire. The therapeutic effects maintained for 3–6 months without continuous administration.”

– “Human Umbilical Cord Mesenchymal Stem Cell Therapy for Patients with Active Rheumatoid Arthritis: Safety and Efficacy,” Wang et al, Stem Cells and Development, 2013

Contact Us to Receive a Quote

Pin It on Pinterest

Share This